阿凡托邦是血小板生成素受體（TPO受體）的新型具口服活性激動(dòng)劑，EC50值為3.3nM，是針對(duì)某些導(dǎo)致血小板減少（異常低血小板計(jì)數(shù)）的病癥而開發(fā)的藥物。
1-Cyclohexylpiperazine
1-(4-Chlorothiophen-2-yl)ethanone
5,6-Dichloropyridine-3-carboxylicacid
4-(4-Chlorothiophen-2-yl)thiazol-2-amine
1-(3-Chloro-5-((4-(4-chlorothiophen-2-yl)-5-(4-cyclohexylpiperazin-1-yl)thiazol-2-yl)carbamoyl)pyridin-2-yl)piperidine-4-carboxylic acid maleate
4-(4-Chlorothiophen-2-yl)-5-(4-cyclohexylpiperazin-1-yl)thiazol-2-amine
5,6-Dichloro-N-(4-(4-chlorothiophen-2-yl)-5-(4-cyclohexylpiperazin-1-yl)thiazol-2-yl)nicotinamide
2-Bromo-1-(4-chlorothiophen-2-yl)ethanone
